Plain-English translation of NCT07236619 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tests a newer heart rhythm treatment called VariPulse that uses electrical pulses instead of heat to treat paroxysmal atrial fibrillation — a condition where your heart beats irregularly. The study wants to find out how long the treatment stays effective by checking your heart rhythm two to three months after your initial procedure to see if the problem areas have reconnected.
Doctors know that reconnection of treated areas is a common reason why this type of heart rhythm treatment sometimes stops working over time. This study wants to understand how well this particular new treatment prevents that reconnection, which could help improve long-term success rates.
You likely qualify if…
You likely don't qualify if…
You will have an initial procedure where the VariPulse catheter is used to treat your irregular heartbeat. Then, 2–3 months later, you will return for a second procedure in which doctors will use special mapping technology to check whether the treated areas have stayed sealed or reconnected, and treat any reconnected areas if needed. Both procedures are performed in a hospital setting and carry similar risks to standard heart rhythm procedures.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Netherlands